Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles|
|Abstract:||Sustained-release microparticle composition. The microparticle composition can be formulated to provide extended release over a period of from about 7 days to about 200 days. The microparticles may be formulated with a biodegradable and biocompatible polymer, and an active agent, such as risperidone, 9-hydroxy-risperidone, and pharmaceutically acceptable acid addition salts of the foregoing.|
|Inventor(s):||Atkins; Thomas J. (York, PA), Rickey; Michael E. (Loveland, OH), Mesens; Jean (Wechelderzande, BE)|
|Assignee:||Alkermes, Inc. (Cambridge, MA) Janssen Pharmaceutica, N.V (Beerse, BE)|
Patent Claim Types:|
see list of patent claims
Back Citations: 99
Forward Citations: 0
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.